Clinical Trials Browser

Recurrent Ovarian High Grade Serous Adenocarcinoma × olaparib × 90 days × Clear all

NCT04633239 2026-03-19

Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer

Phase 1 Recruiting

Recurrent Ovarian High Grade Serous Adenocarcinoma